Open AccessTrial of atorvastatin on serum interleukin-6, total antioxidant capacity, c-reactive protein, and alpha-1 antitrypsin in patients with chronic obstructive pulmonary disease
Author(s) -
Anahita Arian,
Sayyed Gholamreza Mortazavi Moghadam,
Tooba Kazemi,
Mahmoud Zardast,
Asghar Zarban
Publication year - 2018
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/jrpp.jrpp_17_93
Subject(s) - medicine , atorvastatin , copd , gastroenterology , c reactive protein , randomized controlled trial , inflammation
The present study was designed to investigate the effects of atorvastatin on serum high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), total antioxidant capacity (TAC), and alpha-1 antitrypsin (AAT) in patients with chronic obstructive pulmonary disease (COPD).